NuVasive Aktie

Kaufen
Verkaufen
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Bei einem anderen Broker handeln Smartphone
KGV 58,54 Div. Rendite 0,00%

WKN A0CAYR

ISIN US6707041058

Symbol NUVA


NuVasive Aktie Analyse

31.10.18 NuVasive Buy Needham & Company, LLC
17.10.18 NuVasive Buy Needham & Company, LLC
27.09.18 NuVasive Outperform Robert W. Baird & Co. Incorporated
01.08.18 NuVasive Buy Needham & Company, LLC
04.05.18 NuVasive Market Perform BMO Capital Markets
02.05.18 NuVasive Buy Needham & Company, LLC
27.02.18 NuVasive Buy Needham & Company, LLC
04.01.18 NuVasive Buy Needham & Company, LLC
10.11.17 NuVasive Outperform RBC Capital Markets
25.10.17 NuVasive Buy Canaccord Adams
07.09.17 NuVasive Buy BTIG Research
06.06.17 NuVasive Outperform RBC Capital Markets
27.05.16 NuVasive overweight Barclays Capital
09.10.15 NuVasive Outperform BMO Capital Markets
06.10.15 NuVasive Buy Canaccord Adams
29.07.15 NuVasive Outperform Northland Capital
25.02.15 NuVasive Buy Brean Capital
13.01.15 NuVasive Buy WallachBeth
08.01.15 NuVasive Outperform RBC Capital Markets
04.12.14 NuVasive Buy Brean Capital
30.09.14 NuVasive Buy Brean Capital
30.07.12 NuVasive outperform Barrington Research
24.07.12 NuVasive outperform RBC Capital Markets
09.05.12 NuVasive overweight Barclays Capital
02.05.12 NuVasive overweight Barclays Capital
01.03.12 NuVasive outperform Barrington Research
24.02.12 NuVasive overweight Barclays Capital
27.01.12 NuVasive overweight Barclays Capital
18.01.12 NuVasive overweight Barclays Capital
31.10.11 NuVasive overweight Barclays Capital
03.10.11 NuVasive outperform Barrington Research
26.09.11 NuVasive overweight Barclays Capital
11.05.10 NuVasive stark kaufen Needham & Company, LLC
28.11.06 NuVasive Outperform Wachovia Sec
16.10.06 NuVasive Overweight Morgan Stanley
02.08.06 NuVasive Overweight Lehman Brothers
Werbung